BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32487777)

  • 1. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer.
    Lee J; Kim CH; Min IK; Jeong S; Kim H; Choi MJ; Kwon HJ; Jung SG; Jo YS
    Eur J Endocrinol; 2020 Jul; 183(1):83-93. PubMed ID: 32487777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma.
    Kim HI; Hyeon J; Park SY; Ahn HS; Kim K; Han JM; Bae JC; Shin JH; Kim JS; Kim SW; Chung JH; Kim TH; Oh YL
    Thyroid; 2019 Jul; 29(7):963-970. PubMed ID: 31025609
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
    Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
    J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary Thyroid Cancer.
    Seok J; Ryu CH; Park SY; Lee CY; Lee YK; Hwangbo Y; Lee EK; Lee YJ; Kim TS; Kim SK; Jung YS; Ryu J
    Otolaryngol Head Neck Surg; 2021 Oct; 165(4):519-527. PubMed ID: 33560176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
    Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
    Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Value of Lymph Node Ratio Integration with the 8
    Lee J; Lee SG; Kim K; Yim SH; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS
    Sci Rep; 2019 Sep; 9(1):13361. PubMed ID: 31527831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence.
    Park YM; Lee BJ
    Sci Rep; 2021 Mar; 11(1):4948. PubMed ID: 33654166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
    Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
    Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of the presence of extranodal extension in the metastatic node of differentiated thyroid cancer: a proposal for modification in the American Thyroid Association (ATA) risk stratification.
    Chidambaranathan N; Thiagarajan S; Gurukeerthi B; Sathe P; Samel P; Ramalingam N; Chaukar D
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1923-1931. PubMed ID: 38189969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Metastatic Lymph Nodes on Risk Stratification in Differentiated Thyroid Cancer: Have We Reached a Higher Level of Understanding?
    Urken ML; Haser GC; Likhterov I; Wenig BM
    Thyroid; 2016 Apr; 26(4):481-8. PubMed ID: 26892765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes.
    Rowe ME; Ozbek U; Machado RA; Yue LE; Hernandez-Prera JC; Valentino A; Qazi M; Brandwein-Weber M; Liu X; Wenig BM; Urken ML
    Endocr Pathol; 2018 Mar; 29(1):80-85. PubMed ID: 29396810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Lymph Node Counts in American Thyroid Association Low-Risk Papillary Thyroid Carcinoma Patients.
    Griffin MJ; Baik FM; Brandwein-Weber M; Qazi M; Yue LE; Osorio M; Urken ML
    World J Surg; 2020 Jun; 44(6):1892-1897. PubMed ID: 32055968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric Analysis of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Digital Pathology.
    Kim CA; An HR; Yoo J; Lee YM; Sung TY; Kim WG; Song DE
    Endocr Pathol; 2024 Jun; 35(2):113-121. PubMed ID: 38064165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence.
    Jianyong L; Jinjing Z; Zhihui L; Tao W; Rixiang G; Jingqiang Z
    Thyroid; 2018 Mar; 28(3):301-310. PubMed ID: 29439612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
    Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
    World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for non-small-volume central lymph node metastases (more than 5 or ≥ 2 mm) in clinically node-negative papillary thyroid carcinoma.
    Wang JB; Sun YY; Shi LH; Xie L
    Medicine (Baltimore); 2019 Jan; 98(1):e14028. PubMed ID: 30608456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
    Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
    Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study.
    van Kinschot CMJ; Oudijk L; van Noord C; Korevaar TIM; van Nederveen FH; Peeters RP; van Kemenade FJ; Visser WE
    Eur J Endocrinol; 2024 May; 190(5):374-381. PubMed ID: 38652802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal Extension Is an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.
    Zhou TH; Lin B; Wu F; Lu KN; Mao LL; Zhao LQ; Jiang KC; Zhang Y; Zheng WJ; Luo DC
    Front Endocrinol (Lausanne); 2021; 12():759049. PubMed ID: 34803921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.